Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global...
Read more
Atea Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapeutics to improve the lives...
Read more
CureVac N.V. a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), announced...
Read more
Roche announced that the European Commission has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult...
Read more
Gilead Sciences, Inc. announced that the U.S. FDA has approved the antiviral drug Veklury for the treatment of patients with...
Read more
Eli Lilly and Company and Incyte announced positive data for Olumiant will be presented at ACR Convergence 2020, the American...
Read more
Novartis announced that the European Commission (EC) has approved Adakveo (crizanlizumab) for the prevention of recurrent vaso-occlusive crises (VOCs), or...
Read more
Novartis and Molecular Partners AG announced a collaboration in the form of an option and license agreement to develop, manufacture...
Read more
Johnson & Johnson announced today that it is preparing to resume recruitment in the pivotal Phase 3 ENSEMBLE trial of...
Read more
East Lyme, Connecticut, USA: Analysis from Phesi shows the impact of COVID-19 on clinical development is continuing to mount, with...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
